Toronto – August 14, 2024 – With membership across the isotope supply chain, healthcare sector, and academic institutions, the Canadian Nuclear Isotope Council (CNIC) is committed to ensuring that the Canadian medical isotope industry is staffed with sufficient talent with the appropriate training to support its long-term leadership. The CNIC is pleased to announce that … Read more
Toronto – August 7, 2024 – As part of its mission to ensure patients across Canada have access to the highest standard of medical care and nuclear medicine services, the Canadian Nuclear Isotope Council (CNIC) is proud to announce its new collaboration with the More PETs Coalition. The More PETs Coalition is a group of … Read more
Toronto – July 16 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to welcome Agescan International Inc. (Agescan), bringing expertise in medical radiation shielding and strengthening the CNIC’s commitment to innovation and safety in the isotope industry. With customers around the world, Canadian-based Agescan is a rapidly-growing source of tungsten alloy and related … Read more
Toronto, June 10, 2024 – Last week, the Canadian Nuclear Isotope Council (CNIC) celebrated the successful conclusion of the 2024 Canadian Radiotheranostics Leaders’ Summit, held on June 6-7 at the MaRS Discovery District in Toronto. The event was delivered in collaboration with the University Health Network (UHN) and Canadian Medical Isotopes Ecosystem (CMIE), with a … Read more
Toronto – May 28 2024 – Over the past six years, the Canadian Nuclear Isotope Council has worked to expand its membership to encompass the entire isotope production pipeline from coast to coast. Today, CNIC is proud to welcome Rayatom Technologies, an important piece of the Canadian radiopharmaceutical value chain. Based in Kanata, Ontario, Rayatom … Read more
Toronto – May 23, 2024 – The Canadian Nuclear Isotope Council (CNIC) is proud to announce Mirion as its latest member. A leading provider of advanced radiation safety solutions, Mirion offers decades of expertise and a comprehensive suite of technologies to ensure safety, as well as product quality, at every stage of the radiopharmaceutical lifecycle. … Read more
TORONTO – May 21, 2024 – Innovation is not just a trendy buzz word to the Canadian Nuclear Isotope Council’s (CNIC) newest member, Nuclear Promise X (NPX). Instead, it is the very foundation of all their work as they continue to distance themselves as a change leader, helping to push the nuclear industry further into … Read more
Toronto – May 15, 2024– NUCM, a Canadian company that produces GMP Radiopharmaceuticals crucial for medical imaging and treatments, has joined the Canadian Nuclear Isotope Council (CNIC). NUCM is a source for all commonly-used Tc-99m SPECT radiopharmaceuticals and continue to expand their production to additional customized Theranostic Radiopharmaceuticals, and new PET products containing Gallium-68. NUCM … Read more
TORONTO – May 9, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce the addition of Novartis Canada as its newest member. As an innovative medicines company focused on addressing significant areas of unmet medical need, Novartis Canada is well placed to help the CNIC in its efforts to ensure that novel … Read more
Toronto – May 1 2024 – Since its inception, the Canadian Nuclear Isotope Council (CNIC) has been focused on establishing itself as the pre-eminent thought leader for Canadian isotopes through the delivery of authentic and genuine content that leverages the expertise, insight, and experience of the sector and its members to educate the public. Today, … Read more